Powered by LatticeGrid

Search Enter term and hit return. Use '*' for as a wildcard.

Publication Listing for the MeSH term resistance. Found 47 abstracts

no pagination
Nacson J, Krais JJ, Bernhardy AJ, Clausen E, Feng W, Wang Y, Nicolas E, Cai KQ, Tricarico R, Hua X, DiMarcantonio D, Martinez E, Zong D, Handorf EA, Bellacosa A, Testa JR, Nussenzweig A, Gupta GP, Sykes SM, Johnson N. BRCA1 Mutation-Specific Responses to 53BP1 Loss-Induced Homologous Recombination and PARP Inhibitor Resistance. Cell Rep. 2018 Sep 25;24(13):3513-3527e7.   PMCID: PMC6219632
Flynn WF, Haldane A, Torbett BE, Levy RM. Inference of Epistatic Effects Leading to Entrenchment and Drug Resistance in HIV-1 Protease. Molecular biology and evolution. 2017 Mar 20;34(6):1291-306.   PMCID: PMC5435099
Gaponova AV, Deneka AY, Beck TN, Liu H, Andrianov G, Nikonova AS, Nicolas E, Einarson MB, Golemis EA, Serebriiskii IG. Identification of evolutionarily conserved DNA damage response genes that alter sensitivity to cisplatin. Oncotarget. 2017 Mar 21;8(12):19156-71.   PMCID: PMC5386675
Jennings MC, Forman ME, Duggan SM, Minbiole KP, Wuest WM. Efflux Pumps May Not Be the Major Drivers of QAC Resistance in Methicillin-Resistant Staphylococcus aureus. Chembiochem. 2017 Aug 17;18(16):1573-7.   PMCID: PMC5664203
Hakanson M, Kobel S, Lutolf MP, Textor M, Cukierman E, Charnley M. Controlled Breast Cancer Microarrays for the Deconvolution of Cellular Multilayering and Density Effects upon Drug Responses. Plos One. 2012 Jun;7(6):e40141.   PMCID: PMC3387021
Liptrott NJ, Pushpakom S, Wyen C, Fatkenheuer G, Hoffmann C, Mauss S, Knechten H, Brockmeyer NH, Hopper-Borge E, Siccardi M, Back DJ, Khoo SH, Pirmohamed M, Owen A. Association of ABCC10 polymorphisms with nevirapine plasma concentrations in the German Competence Network for HIV/AIDS. Pharmacogenetics and Genomics. 2012 Jan;22(1):10-9.   PMCID: not NIH funded
Mego M, Mani SA, Lee BN, Li CP, Evans KW, Cohen EN, Gao H, Jackson SA, Giordano A, Hortobagyi GN, Cristofanilli M, Lucci A, Reuben JM. Expression of epithelial-mesenchymal transition-inducing transcription factors in primary breast cancer: The effect of neoadjuvant therapy. International journal of cancer. 2012 Feb;130(4):808-16.   PMCID: PMC169728
Schilder RJ, Brady WE, Lankes HA, Fiorica JV, Shahin MS, Zhou XC, Mannel RS, Pathak HB, Hu W, Alpaugh RK, Sood AK, Godwin AK. Phase II evaluation of dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study. Gynecologic Oncology. 2012 Oct;127(1):70-4.   PMCID: PMC 3748717
Shi Z, Yang WM, Chen LP, Yang DH, Zhou Q, Zhu J, Chen JJ, Huang RC, Chen ZS, Huang RP. Enhanced chemosensitization in multidrug-resistant human breast cancer cells by inhibition of IL-6 and IL-8 production. Breast Cancer Research and Treatment. 2012 Oct;135(3):737-47.
Adams SF, Marsh EB, Elmasri W, Halberstadt S, VanDecker S, Sammel MD, Bradbury AR, Daly M, Karlan B, Rubin SC, Belsadron G, Biochimie V P. A high response rate to liposomal doxorubicin is seen among women with BRCA mutations treated for recurrent epithelial ovarian cancer. Gynecologic Oncology. 2011 Dec;123(3):486-91.   PMCID: PMC3260049
Giuliano M, Giordano A, Jackson S, Hess KR, De Giorgi U, Mego M, Handy BC, Ueno NT, Alvarez RH, De Laurentiis M, De Placido S, Valero V, Hortobagyi GN, Reuben JM, Cristofanilli M. Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment. Breast Cancer Research. 2011 Jun;13(3):R67.   PMCID: PMC3218956
Gradilone A, Naso G, Raimondi C, Cortesi E, Gandini O, Vincenzi B, Saltarelli R, Chiapparino E, Spremberg F, Cristofanilli M, Frati L, Agliano AM, Gazzaniga P. Circulating tumor cells (CTCs) in metastatic breast cancer (MBC): prognosis, drug resistance and phenotypic characterization. Annals of Oncology. 2011 Jan;22(1):86-92.   PMCID: not NIH funded
Ingersoll KS, Farrell-Carnahan L, Cohen-Filipic J, Heckman CJ, Ceperich SD, Hettema J, Marzani-Nissen G. A pilot randomized clinical trial of two medication adherence and drug use interventions for HIV plus crack cocaine users. Drug and alcohol dependence. 2011 Jul;116(1-3):177-87.   PMCID: PMC3102141
Lara JF, Thor AD, Dressler LG, Broadwater G, Bleiweiss IJ, Edgerton S, Cowan D, Goldstein LJ, Martino S, Ingle JN, Henderson IC, Norton L, Winer EP, Hudis CA, Ellis MJ, Berry DA, Hayes DF, Canc Leukemia Grp B. p53 Expression in Node-Positive Breast Cancer Patients: Results from the Cancer and Leukemia Group B 9344 Trial (159905). Clinical Cancer Research. 2011 Aug;17(15):5170-8.   PMCID: PMC319770
Reuben JM, Lee BN, Gao H, Cohen EN, Mego M, Giordano A, Wang XM, Lodhi A, Krishnamurthy S, Hortobagyi GN, Cristofanilli M, Lucci A, Woodward WA. Primary breast cancer patients with high risk clinicopathologic features have high percentages of bone marrow epithelial cells with ALDH activity and CD44(+)CD24(lo) cancer stem cell phenotype. European Journal of Cancer. 2011 Jul;47(10):1527-36.   PMCID: PMC3116032
Belyi VA, Levine AJ, Skalka AM. Unexpected Inheritance: Multiple Integrations of Ancient Bornavirus and Ebolavirus/Marburgvirus Sequences in Vertebrate Genomes. Plos Pathogens. 2010 Jul;6(7).   PMCID: PMC2912400
van Vlerken LE, Duan ZF, Little SR, Seiden MV, Amiji MM. Augmentation of Therapeutic Efficacy in Drug-Resistant Tumor Models Using Ceramide Coadministration in Temporal-Controlled Polymer-Blend Nanoparticle Delivery Systems. Aaps Journal. 2010 Jun;12(2):171-80.   PMCID: PMC2844507 [Available on 2011/2/9]
Hopper-Borge EA, Nasto RE, Ratushny V, Weiner LM, Golemis EA, Astsaturov I. Mechanisms of tumor resistance to EGFR-targeted therapies. Expert Opinion on Therapeutic Targets. 2009 Mar;13(3):339-62.   PMCID: PMC2670612
Rink L, Skorobogatko Y, Kossenkov AV, Belinsky MG, Pajak T, Heinrich MC, Blanke CD, von Mehren M, Ochs MF, Eisenberg B, Godwin AK. Gene expression signatures and response to imatinib mesylate in gastrointestinal stromal tumor. Molecular Cancer Therapeutics. 2009 Aug;8(8):2172-82.   PMCID: PMC2822341
Reeves A, Zagurovskaya M, Gupta S, Shareef MM, Mohiuddin M, Ahmed MM. Inhibition of transforming growth factor-beta signaling in normal lung epithelial cells confers resistance to ionizing radiation. International Journal of Radiation Oncology Biology Physics. 2007 May;68(1):187-95.
The above publications are sorted by year, faculty last name, and first author. Click on any highlighted author listed to find all publications attributed to that individual. Click on the publication title to see the abstract. First authors who are faculty are highlighted like this. Last authors who are faculty are highlighted like this. Other authors who are faculty are highlighted like this.

MeSH cloud from publications including the MeSH term resistance

resistance survival progression therapy expression kinase inhibitor cells circulating tumor cells breast cancer HIV bevacizumab carcinoma chemotherapy predictive-value bcl-2 Motivational Interviewing plus feedback acute myeloid-leukemia drugs Crack cocaine PARP inhibitors tissue architecture zinc-finger genes bms-354825 combination therapy rna BRCA mutations adjuvant chemotherapy BREAST-CANCER cetuximab micrometastases cip1) protease inhibitors ABC transporter cell death IL-6 Cytokine-IL-8-Drug resistance-Cytokine antibody arrays art ACTIVATION beta(1) integrin interleukin-6 Triple-receptor phase-ii growth LINE MIA PACA-2 normal lung cells ph-sensitive system marker DIFFERENTIATION nonnucleoside reverse-transcriptase intracellular ceramide modulation behavioral skills model multidrug-resistance tumor-suppressor gene P53 DNA damage response platinating agents poly(beta-amino ester) nanoparticles temporal-controlled polymeric nanoparticle delivery II RECEPTOR Adherence Brca1 homologous recombination solid tumors epithelial ovarian-cancer profile macrophage mutational landscape epistasis-statistical inference-coevolution-HIV-drug gists nucleoside antiretroviral therapy adherence ebola-virus ovarian-cancer topotecan 53bp1 Video intervention efavirenz single nucleotide polymorphism neoadjuvant therapy transporter platinum drug recombination serum-levels monocyte-derived estrogen-receptor improve adherence reliability CANCER association molecular phylogeny Ovarian cancer anticancer population pharmacokinetics NETWORK head and neck cancer autocrine production glycoprotein viral suppression ACUTE MYELOID-LEUKEMIA oophorectomy cytokines slug identification CELL LUNG-CANCER protein-7 abcc10 PHASE-III TRIAL tyrosine kinase disease-virus TYROSINE KINASE INHIBITORS array technology circulating tumor-cells ABCC10 METASTATIC COLORECTAL-CANCER extracellular-matrix p21(waf1 kit mutations prognostic-significance targeted delivery neuropsychiatric interview mini viruses mammalian genomes PROTEIN-INTERACTION hiv-infected patients nevirapine erlotinib differential-diagnosis primary kinase inhibitor p27(kip1) in-vitro quaternary ammonium compound methicillin-resistant Staphylococcus aureus qac immunogenicity modulation caveolin-1 ionizing radiation epithelial-mesenchymal transition network tumors glucosylceramide monocyte chemotactic protein-1 Ovarian Dasatinib-Cancer-SRC-Inhibition EGFR GENE COPY NUMBER DRUG-RESISTANCE GROWTH-FACTOR-RECEPTOR PANCREATIC-CARCINOMA EXPRESSION paclitaxel drug efflux transporter nucleoprotein TGF-BETA sexual risk behaviors
Last updated on Wednesday, August 12, 2020